Chloé Journo

823 total citations
34 papers, 641 citations indexed

About

Chloé Journo is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Chloé Journo has authored 34 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 20 papers in Ecology, Evolution, Behavior and Systematics and 20 papers in Agronomy and Crop Science. Recurrent topics in Chloé Journo's work include T-cell and Retrovirus Studies (24 papers), Animal Disease Management and Epidemiology (20 papers) and Vector-Borne Animal Diseases (20 papers). Chloé Journo is often cited by papers focused on T-cell and Retrovirus Studies (24 papers), Animal Disease Management and Epidemiology (20 papers) and Vector-Borne Animal Diseases (20 papers). Chloé Journo collaborates with scholars based in France, Lebanon and United States. Chloé Journo's co-authors include Renaud Mahieux, Hélène Dutartre, Sandrine Alais, Ali Bazarbachi, Sébastien Alain Chevalier, Nga Ling Ko, Youmna Kfoury, Claudine Pique, Antoine Gessain and Rihab Nasr and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Chloé Journo

33 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chloé Journo France 17 471 336 309 168 57 34 641
Sébastien Alain Chevalier France 17 610 1.3× 493 1.5× 412 1.3× 179 1.1× 82 1.4× 27 813
Isabelle Clerc France 12 363 0.8× 216 0.6× 192 0.6× 138 0.8× 56 1.0× 17 550
Andrea K. Thoma‐Kress Germany 13 323 0.7× 219 0.7× 197 0.6× 116 0.7× 49 0.9× 29 472
Sabine Thébault France 12 540 1.1× 420 1.3× 409 1.3× 206 1.2× 49 0.9× 15 735
Paola Miyazato Japan 16 790 1.7× 648 1.9× 597 1.9× 132 0.8× 45 0.8× 31 967
Luca Casareto United States 9 431 0.9× 260 0.8× 258 0.8× 126 0.8× 98 1.7× 10 581
Michi Miura Japan 12 353 0.7× 286 0.9× 275 0.9× 107 0.6× 36 0.6× 20 527
Anne Van den Broeke Belgium 18 878 1.9× 685 2.0× 553 1.8× 247 1.5× 36 0.6× 42 1.1k
Garret C. Newbound United States 9 374 0.8× 301 0.9× 296 1.0× 142 0.8× 26 0.5× 16 530
Gilles Gaudray France 7 577 1.2× 463 1.4× 437 1.4× 106 0.6× 27 0.5× 7 680

Countries citing papers authored by Chloé Journo

Since Specialization
Citations

This map shows the geographic impact of Chloé Journo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloé Journo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloé Journo more than expected).

Fields of papers citing papers by Chloé Journo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloé Journo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloé Journo. The network helps show where Chloé Journo may publish in the future.

Co-authorship network of co-authors of Chloé Journo

This figure shows the co-authorship network connecting the top 25 collaborators of Chloé Journo. A scholar is included among the top collaborators of Chloé Journo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloé Journo. Chloé Journo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhong, Li, Rustem Uzbekov, Xuan-Nhi Nguyen, et al.. (2022). A novel domain within the CIL regulates egress of IFITM3 from the Golgi and reveals a regulatory role of IFITM3 on the secretory pathway. Life Science Alliance. 5(7). e202101174–e202101174. 6 indexed citations
3.
Dumont, Claire, Mathieu Iampietro, Louis-Marie Bloyet, et al.. (2021). Nipah virus W protein harnesses nuclear 14-3-3 to inhibit NF-κB-induced proinflammatory response. Communications Biology. 4(1). 1292–1292. 16 indexed citations
4.
Journo, Chloé, et al.. (2020). Microbial Biofilms: Human T-cell Leukemia Virus Type 1 First in Line for Viral Biofilm but Far Behind Bacterial Biofilms. Frontiers in Microbiology. 11. 2041–2041. 15 indexed citations
5.
Verlhac, Pauline, Yakubu Princely Abudu, Mathias Faure, et al.. (2019). SQSTM-1/p62 potentiates HTLV-1 Tax-mediated NF-κB activation through its ubiquitin binding function. Scientific Reports. 9(1). 16014–16014. 17 indexed citations
6.
Journo, Chloé, Renaud Mahieux, Vincenzo Ciminale, et al.. (2019). TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins. Frontiers in Microbiology. 10. 1302–1302. 17 indexed citations
7.
Gruffat, Henri, et al.. (2019). Viral oncogenesis and genomic instability: the centr(osom)al connection. Virologie. 23(5). 304–320. 1 indexed citations
8.
Wu, Nannan, Xuan-Nhi Nguyen, Li Wang, et al.. (2019). The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation. PLoS Pathogens. 15(10). e1008093–e1008093. 41 indexed citations
9.
Turpin, Jocelyn, Ali Bazarbachi, Valérie Lallemand-Breitenbach, et al.. (2018). Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner. Oncogene. 37(21). 2806–2816. 12 indexed citations
10.
Journo, Chloé, et al.. (2018). Un double effet antiviral des IFITM sur les virus enveloppés. médecine/sciences. 34(3). 214–218. 1 indexed citations
11.
Alais, Sandrine, Loïc Roux, Maria‐Isabel Thoulouze, et al.. (2018). How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy. Frontiers in Microbiology. 9. 278–278. 26 indexed citations
12.
Alais, Sandrine, Chloé Journo, Réjane Rua, et al.. (2018). STLV-1 co-infection is correlated with an increased SFV proviral load in the peripheral blood of SFV/STLV-1 naturally infected non-human primates. PLoS neglected tropical diseases. 12(10). e0006812–e0006812. 17 indexed citations
13.
Alais, Sandrine, et al.. (2017). Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells. PLoS Pathogens. 13(4). e1006353–e1006353. 31 indexed citations
14.
Shirinian, Margret, Zakaria Kambris, Caroline Grabbe, et al.. (2015). A Transgenic Drosophila melanogaster Model To Study Human T-Lymphotropic Virus Oncoprotein Tax-1-Driven Transformation In Vivo. Journal of Virology. 89(15). 8092–8095. 21 indexed citations
15.
Hajj, Hiba El, Akram Ghantous, Ahmad Daher, et al.. (2013). Combination of Arsenic and Interferon-α Inhibits Expression of KSHV Latent Transcripts and Synergistically Improves Survival of Mice with Primary Effusion Lymphomas. PLoS ONE. 8(11). e79474–e79474. 5 indexed citations
16.
Chevalier, Sébastien Alain, Sandrine Alais, Nga Ling Ko, et al.. (2013). Alpha Interferon Restricts Human T-Lymphotropic Virus Type 1 and 2 De Novo Infection through PKR Activation. Journal of Virology. 87(24). 13386–13396. 24 indexed citations
17.
Kfoury, Youmna, Rihab Nasr, Chloé Journo, et al.. (2012). The Multifaceted Oncoprotein Tax. Advances in cancer research. 113. 85–120. 39 indexed citations
18.
Journo, Chloé, Josina Filipe, Frédégonde About, et al.. (2009). NRP/Optineurin Cooperates with TAX1BP1 to Potentiate the Activation of NF-κB by Human T-Lymphotropic Virus Type 1 Tax Protein. PLoS Pathogens. 5(7). e1000521–e1000521. 71 indexed citations
19.
20.
Journo, Chloé & Jean‐Lou Justine. (2006). Laticola dae n. sp. (Monogenea: Diplectanidae) from Epinephelus maculatus (Perciformes: Serranidae) off New Caledonia. Systematic Parasitology. 64(3). 173–180. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026